Journal Article10.1016/J.ANCARD.2020.07.005
Long-term prognosis of patients with permanent cardiac pacemaker indication in three referral cardiac centers in Cameroon: Insights from the National pacemaker registry.
Anastase Dzudie,C. Ngongang Ouankou,L. Nganhyim,Sidick Mouliom,H. Ba,Félicité Kamdem,Jules Ndjebet,A. Nzali,Cabral Tantchou,Clovis Nkoke,B. Barche,Martin Hongieh Abanda,U.A. Metogo Mbengono,R. Hentchoya,C. Petipe Nkappe,M. Ouankou,C. Kouam Kouam,P. Mintom,Jerome Boombhi,L. Kuate Mfeukeu,William Ngatchou,Samuel Kingue,M. Ngowe Ngowe +22 more
1
TL;DR: The authors' patients with severe heart blocks presented late and more than a quarter did not have access to pacemaker but its implantation multiplied the survival rate by 2.7 times at approximately 3 years post diagnosis, suggesting improving early detection of heart blocks and access to cardiac pacing to reduce mortality shall be a key future priority.
read more
Abstract: Background There is evidence that cardiac pacemakers improve symptoms and quality of life in patients with severe bradycardia. Globally, the number of pacemaker implantations is on the rise. However, the associated high-cost limits pacemaker's accessibility in low resource settings. This study aimed to investigate access to pacemakers and the long-term outcome of patients requiring a pacemaker. Method We conducted a cohort study in 03 health care structures in Cameroon. Participants aged at least 18 years with indication for a permanent pacemaker between January 2010 and May 2016 were included. Clinical profile, electrocardiography, pacemaker implantation parameters were recorded. Long-term survival was studied by event-free analysis using the Kaplan-Meier method. Results In total, 147 participants (mean age 67.7 ± 13.7 years, female 58.5%) were included. Fatigue (78.7%), dyspnoea (77.2%), dizziness (47.1%) and palpitations (40.4%) were the main symptoms while syncope was present in 35.7% of patients. The main indication for cardiac pacemaker was atrioventricular block (85.3%). Forty (27.2%) could not be implanted with 34 (85%) of participants highlighting cost of intervention as main reason. VVIR was the main mode of stimulation (70.5%). Of 125 patients in which follow-up was ascertained, 17(13.5%) died after a median survival time of 2.8 years post diagnosis [IQR: 1.8–4.2]. The survival curve was better in participants with a pacemaker with a Hazard ratio of 2.7 [CI: 1.0–7.3, P = 0.045]. Conclusion Our patients with severe heart blocks presented late and more than a quarter did not have access to pacemaker but its implantation multiplied the survival rate by 2.7 times at approximately 3 years post diagnosis. Improving early detection of heart blocks and access to cardiac pacing to reduce mortality shall be a key future priority.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Survey on Energy Harvesting for Biomedical Devices: Applications, Challenges and Future Prospects for African Countries
Djakou Nekui Olivier,Wei Wang,Cheng Liu,Zhixiao Wang,Bei Ding +4 more
- 27 Dec 2023
TL;DR: This article provides a comprehensive review of self-powered devices in the biomedical research field, introduces their applications for healthcare, and evaluates their status in Africa by providing a thorough review of existing biomedical device initiatives and available financial and scientific cooperation institutions in Africa.
References
Trends in Permanent Pacemaker Implantation in the United States From 1993 to 2009: Increasing Complexity of Patients and Procedures
Arnold J. Greenspon,Jasmine D. Patel,Jasmine D. Patel,Edmund Lau,Edmund Lau,Jorge A. Ochoa,Daniel R. Frisch,Reginald T. Ho,Behzad B. Pavri,Steven M. Kurtz,Steven M. Kurtz +10 more
TL;DR: There is a steady growth in the use of permanent pacemakers in the United States, although DDD device use is increasing, whereas single-chamber ventricular pacemaker use is decreasing.
477
Mortality from cardiovascular diseases in sub-Saharan Africa, 1990-2013: a systematic analysis of data from the Global Burden of Disease Study 2013.
George A. Mensah,Gregory A. Roth,Uchechukwu K.A. Sampson,Andrew E. Moran,Valery L. Feigin,Mohammad H. Forouzanfar,Mohsen Naghavi,Christopher J L Murray,Gbd Mortality +8 more
TL;DR: In this paper, the authors estimate the number of deaths, death rates, and their trends for CVD causes of death in sub-Saharan Africa, by age and gender for 1990 and 2013.
306
Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions.
TL;DR: Prevention, detection, treatment and control of cardiovascular disease in sub-Saharan Africa are haphazard and suboptimal due to a combination of lack of resources and health-care systems, non-existent effective preventive strategies at a population level, lack of sustainable drug therapy, and barriers to complete compliance with prescribed medications.
Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association
M.J. Pekka Raatikainen,David O. Arnar,Katja Zeppenfeld,José L. Merino,Francisco Levya,Gerhardt Hindriks,Karl-Heinz Kuck +6 more
TL;DR: These statistics indicate that despite significant improvements, there still is considerable heterogeneity in the availability of arrhythmia therapies across the ESC area.